0001231919-19-000056.txt : 20191122 0001231919-19-000056.hdr.sgml : 20191122 20191122143148 ACCESSION NUMBER: 0001231919-19-000056 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191122 DATE AS OF CHANGE: 20191122 EFFECTIVENESS DATE: 20191122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adjuvance Technologies Inc. CENTRAL INDEX KEY: 0001652786 IRS NUMBER: 270510244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-349477 FILM NUMBER: 191240705 BUSINESS ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 2128459809 MAIL ADDRESS: STREET 1: 16 WEST 22ND STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 D/A 1 primary_doc.xml X0708 D/A LIVE 0001652786 Adjuvance Technologies Inc. 1225 L Street, Suite 600 Lincoln NE NEBRASKA 68508 4028175050 DELAWARE None None Corporation true J. Tyler Martin 1225 L Street, Suite 600 1225 L Street, Suite 600 Lincoln NE NEBRASKA 68508 Executive Officer Director Isaac Cheng c/o Adjuvance Technologies Inc. 1225 L Street, Suite 600 Lincoln NE NEBRASKA 68508 Director Ken Kelley c/o Adjuvance Technologies Inc. 1225 L Street, Suite 600 Lincoln NE NEBRASKA 68508 Director Stephen Dilly c/o Adjuvance Technologies Inc. 1225 L Street, Suite 600 Lincoln NE NEBRASKA 68508 Director Biotechnology Decline to Disclose 06b true 0001231919-19-000051 2019-08-29 false true false 0 24657194 10657192 14000002 false 28 0 0 0 false Adjuvance Technologies Inc. /s/ J. Tyler Martin J. Tyler Martin Chief Executive Officer 2019-11-22